NPSGX Performance — Nicholas Partners Small Cap Growth Fund, Institutional Shares
Data updated: 2026-08-28
NPSGX returned +32.61% year to date and +60.29% over one year to Jun 2026. Annualised returns are +25.05% over 3 years and +8.95% over 5 years. The fund beat its US Mid-Cap Growth category average: $100 invested three years ago grew to $196, against $152 for the category, and to $160 over one year, against $118. Volatility over the past three years was 21.28% a year. In the 12 months to Jun 2026 the fund took in a net $16.6M, and assets reached $193.51M.
NPSGX Growth of $100
What $100 invested in Nicholas Partners Small Cap Growth Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Growth category average over the same months.
| Period | NPSGX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $160 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $196 | $152 |
| 5 years (Jul 2021 – Jun 2026) | $153 | $129 |
| Since data start (Jan 2020 – Jun 2026) | $285 | $193 |
NPSGX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +32.61% |
| 1 year | +60.29% |
| 3 years (annualised) | +25.05% |
| 5 years (annualised) | +8.95% |
NPSGX Annual Returns
Calendar-year total returns of Nicholas Partners Small Cap Growth Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +32.61% |
| 2025 | +17.83% |
| 2024 | +18.58% |
| 2023 | +20.05% |
| 2022 | −31.62% |
| 2021 | +10.40% |
| 2020 | +69.65% |
NPSGX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −4.1% | +0.6% | +7.2% | +4.2% | +6.4% | +15.7% | — | — | — | — | — | — |
| 2025 | −8.9% | −6.9% | +2.6% | +7.8% | +3.0% | +0.9% | +4.9% | +5.8% | +5.0% | −0.2% | −1.4% | +5.4% |
| 2024 | +1.8% | +11.3% | +1.9% | −0.5% | +4.4% | −7.1% | +0.9% | +0.6% | +4.5% | −8.5% | +11.5% | −1.6% |
| 2023 | −2.5% | −0.4% | +5.7% | +8.0% | +1.4% | +1.1% | −6.5% | −3.4% | +3.8% | +11.4% | +9.6% | −7.7% |
| 2022 | +1.2% | +2.5% | −16.1% | −6.0% | −4.2% | −14.3% | −7.4% | +1.4% | +9.0% | −6.1% | +2.0% | +4.0% |
| 2021 | −6.2% | +7.8% | +0.2% | +4.4% | −1.6% | +5.0% | −1.9% | +2.5% | 0.0% | −0.1% | −4.6% | +5.2% |
| 2020 | −16.3% | −5.9% | −0.7% | +4.0% | +15.0% | +18.7% | +1.4% | +7.9% | +5.4% | +10.7% | +15.9% | +3.3% |
NPSGX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 21.28%
- 3-year Sharpe ratio: 0.97 (vs 4.5% risk-free rate)
- Best month: +15.68% (Jun 2026)
- Worst month: −8.91% (Jan 2025)
NPSGX Fund Flows
Monthly money in and out of Nicholas Partners Small Cap Growth Fund, from SEC Form N-PORT.
- 12-month net flow: $16.6M
- 12-month gross sales (incl. reinvestments): $21.8M
- Sales ÷ redemptions: 4.18×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $1.1M | $130K | $980K |
| May 2026 | $734K | $284K | $451K |
| Apr 2026 | $628K | $272K | $356K |
| Mar 2026 | $1.1M | $165K | $892K |
| Feb 2026 | $722K | $245K | $476K |
| Jan 2026 | $430K | $169K | $261K |
| Dec 2025 | $3.6M | $337K | $3.2M |
| Nov 2025 | $1.6M | $3.3M | −$1.7M |
| Oct 2025 | $9.5M | $99K | $9.4M |
| Sep 2025 | $12K | $110K | −$97K |
| Aug 2025 | $57K | $15K | $42K |
| Jul 2025 | $2.3M | $71K | $2.2M |
NPSGX Assets Under Management
Net assets of Nicholas Partners Small Cap Growth Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $193.51M |
| 2026-03-31 | $149.33M |
| 2025-12-31 | $142.91M |
| 2025-09-30 | $133.06M |
| 2025-06-30 | $112.27M |
| 2025-03-31 | $99.90M |
| 2024-12-31 | $124.28M |
| 2024-09-30 | $125.68M |
| 2024-06-30 | $116.62M |
| 2024-03-31 | $115.93M |
| 2023-12-31 | $102.08M |
| 2023-09-30 | $91.71M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.